ResearcherRoyal Marsden NHS Foundation TrustNo recent work listed
Shelize Sadrudin Khakoo
Matched on ORCID iD 0000-0003-1142-8152; OpenAlex author ID A5013736494. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 3
- Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis. Co-author DOI 10.1186/s12876-023-02853-w↗
- Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome? Co-author DOI 10.3390/cancers13174396↗
- Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality? Co-author DOI 10.3390/cancers11081095↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Fausto Petrelli · 3 shared papers, 2019–2023 · strength 0.41
- Paper Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-a… DOI 10.1186/s12876-023-02853-w↗
- Paper Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome? DOI 10.3390/cancers13174396↗
- Paper Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality? DOI 10.3390/cancers11081095↗
- Gianluca Tomasello · 3 shared papers, 2019–2023 · strength 0.41
- Paper Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-a… DOI 10.1186/s12876-023-02853-w↗
- Paper Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome? DOI 10.3390/cancers13174396↗
- Paper Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality? DOI 10.3390/cancers11081095↗
- Michele Ghidini · 3 shared papers, 2019–2023 · strength 0.41
- Paper Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-a… DOI 10.1186/s12876-023-02853-w↗
- Paper Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome? DOI 10.3390/cancers13174396↗
- Paper Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality? DOI 10.3390/cancers11081095↗
- Angelica Petrillo · 2 shared papers, 2019–2021 · strength 0.23
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.